Use of proton pump inhibitors and cholangitis complicated with multi-drug resistant bacteria.
Ryunosuke HakutaYousuke NakaiTsuyoshi HamadaYusuke NomuraTomotaka SaitoNaminatsu TakaharaSuguru MizunoHirofumi KogureKyoji MoriyaKazuhiko KoikePublished in: Journal of hepato-biliary-pancreatic sciences (2021)
Regular PPI use was associated with a higher risk of cholangitis with MDRB.